CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,770 | 69,770 | ||
| 2018-12-31 | THERO JOHN F President and CEO | Option exercise | +37,500 | 2,132,028 | ||
| 2018-12-31 | THERO JOHN F President and CEO | Shares withheld for taxes | −14,757 | $13.24 | $195K | 2,117,271 |
| 2018-12-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −37,500 | 75,000 | ||
| 2018-12-28 | Zakrzewski Joseph S Director | Sale | −141,500 | $13.19 | $1.9M | 84,547 |
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,604 | $1.40 | $4K | 343,901 |
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +4,167 | $2.50 | $10K | 348,068 |
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,750 | $2.50 | $9K | 351,818 |
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,750 | $2.50 | $9K | 355,568 |
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,771 | $2.95 | $8K | 358,339 |
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Sale | −17,042 | $17.79 | $303K | 341,297 |
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,604 | 36,458 | ||
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,167 | 29,165 | ||
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,750 | 26,250 | ||
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,750 | 56,688 | ||
| 2018-11-30 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,771 | 72,540 | ||
| 2018-11-30 | Kennedy Joseph T General Counsel | Option exercise | +1,953 | $1.02 | $2K | 219,887 |
| 2018-11-30 | Kennedy Joseph T General Counsel | Option exercise | +2,604 | $1.40 | $4K | 222,491 |
| 2018-11-30 | Kennedy Joseph T General Counsel | Option exercise | +18,749 | $2.50 | $47K | 241,240 |
| 2018-11-30 | Kennedy Joseph T General Counsel | Sale | −23,306 | $17.81 | $415K | 217,934 |
Page 78 of 95 · 1,885 trades